UK Markets closed

Genmab A/S (GNMSF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
421.50-4.92 (-1.15%)
At close: 3:56PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 528.4B
Enterprise value 39.69B
Trailing P/E 31.00
Forward P/E 155.68
PEG ratio (5-yr expected) 1202.04
Price/sales (ttm)2.63
Price/book (mrq)1.37
Enterprise value/revenue 30.90
Enterprise value/EBITDA 71.38

Trading information

Stock price history

Beta (5Y monthly) 0.59
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 3500.92
52-week low 3299.08
50-day moving average 3462.04
200-day moving average 3403.32

Share statistics

Avg vol (3-month) 3553
Avg vol (10-day) 31.06k
Shares outstanding 565.34M
Implied shares outstanding 6N/A
Float 64.67M
% held by insiders 14.63%
% held by institutions 151.84%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021

Profitability

Profit margin 51.71%
Operating margin (ttm)62.93%

Management effectiveness

Return on assets (ttm)22.65%
Return on equity (ttm)32.38%

Income statement

Revenue (ttm)10.8B
Revenue per share (ttm)165.53
Quarterly revenue growth (yoy)77.20%
Gross profit (ttm)10.11B
EBITDA 7.05B
Net income avi to common (ttm)5.58B
Diluted EPS (ttm)13.60
Quarterly earnings growth (yoy)307.40%

Balance sheet

Total cash (mrq)18.08B
Total cash per share (mrq)276.57
Total debt (mrq)378M
Total debt/equity (mrq)1.88
Current ratio (mrq)15.42
Book value per share (mrq)307.34

Cash flow statement

Operating cash flow (ttm)5.7B
Levered free cash flow (ttm)4.25B